The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery

Vascular Pharmacology

Volumn 42, Issue 3, 2005, Pages 119-123

  Lazar, Harold L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACE inhibitors; CABG surgery

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ICATIBANT; QUINAPRIL; QUINAPRILAT; RAMIPRIL;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; ENZYME ACTIVATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; HOLTER MONITORING; HUMAN; NEPHROTOXICITY; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

EID: 15744399575     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.01.012     Document Type: Review

References (27)

1. T.J. Anderson, E. Elstein, H. Haber, and F. Charbonneau Comparative Study of ACE inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilatation in patients with coronary disease (BANFF) study J. Am. Coll. Cardiol. 35 2000 60 66
2. J.A.A. Borland, A.H. Chester, S. Crabbe, J.B. Parkerson, J.D. Catravas, and M.H. Yacoub Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts J. Thorac. Cardiovasc. Surg. 116 1998 206 212
3. M.B. Britten, A.M. Zeiher, and V. Schachinger Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options J. Intern. Med. 245 1999 315 327
4. N.J. Brown, M.A. Agirbajli, G.H. Williams, W.R. Litchfield, and D.E. Vaughan Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1 Hypertension 32 1998 965 971
5. F. Diet, R.E. Pratt, G.J. Berry, N. Momose, G.H. Gibbons, and V.J. Dzau Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease Circ. 94 1996 2756 2767
6. V.J. Dzau Tissue renin-angiotensin system in myocardial hypertrophy Arch. Intern. Med. 153 1993 937 942
7. R. Engelman, J.A. Rousou, J. Iyengar, and D. Das Captopril, an ACE inhibitor for optimizing reperfusion after acute myocardial infarction Ann. Thorac. Surg. 52 1991 918 926
8. J. Gurevitch, D. Pevni, and T. Frolkis Captopril in cardioplegia and reperfusion: protective effects on the ischemic heart Ann. Thorac. Surg. 63 1997 627 633
9. W. Hamsten, G. Wiman, U. Defaire, and M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator inhibitor activity in young survivors of myocardial infarction N. Engl. J. Med. 313 1985 1557 1563
10. J.C. Hartman The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors Ann. Thorac. Surg. 60 1995 789 792
11. N. Hayashida, S. Chihara, and E. Tayama Effects of angiotensin-converting enzyme inhibitor during warm blood cardioplegia Ann. Thorac. Surg. 70 2000 627 632
12. B. Hornig, C. Kohler, and H. Drexler Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans Circ. 95 1997 1115 1118
13. HOPE Investigators Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N. Engl. J. Med. 342 2000 145 153
14. S. Hoshida, N. Yamashita, K. Kawahara, T. Kuzuga, and M. Hori Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis Circ. 99 1999 434 440
15. S. Hoshida, J. Kato, and M. Nishino Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome Circ. 103 2001 630 633
16. L. Knoller-Hansen, R. Steffesnsen, and P. Grande The Angiotensin- converting enzyme inhibition Post-Revascularization Study (APRES) J. Am. Coll. Cardiol. 35 2000 881 888
17. H.L. Lazar, Y. Bao, S. Rivers, T. Colton, and S.A. Bernard High-tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size Ann. Thorac. Surg. 72 2001 548 554
18. H.L. Lazar, Y. Bao, S. Rivers, and S. Bernard Pre-treatment with angiotensin-converting inhibitors attenuates ischemic reperfusion injury during coronary revascularization Ann. Thorac. Surg. 73 2002 1522 1527
19. J.H. O'Keefe, M. Wetzel, R.R. Moe, K. Brosnahan, and C.H. Lavie Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease J. Am. Coll. Cardiol. 37 2001 1 8
20. T. Okimoto, M. Imazu, and Y. Hayaghi Quinapril with high affinity to tissue angiotensin-converting enzyme inhibitor reduces restenosis after percutaneous transcatheter coronary revascularization J. Am. Coll. Cardiol. 35 2000 37A
21. M. Oosterga, A.A. Voors, and V.M. Pinto Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUOVADIS study) J. Am. Coll. Cardiol. 87 2001 542 546
22. M.A. Pfeffer, S.C. Greaves, and J.M. Arnold Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The Healing and Early Afterload Reducing Therapy Trial Circ. 95 1997 2643 2651
23. S. Rajagopalan, S. Kurz, and T. Munzel Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADHNADPH oxidase activation: contribution to alterations of vasomotor tone J. Clin. Invest. 97 1996 1916 1923
24. F. Ribichini, F. Pugno, and V. Ferrero Angiotensin-converting enzyme tissue activity in the diffuse in-stent restenotic plaque Circ. 101 2000 33 35
25. S. Sirivella, I. Gielchinsky, and V. Parsonnett Angiotensin-converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: a prospective randomized study J. Card. Surg. 13 1998 11 17
26. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N. Engl. J. Med. 325 1991 293 302
27. D.E. Vaughan, J.L. Rouleau, P.M. Ridker, M.O. Arnold, F.J. Renapace, and M.A. Pfeffer Effects of ramapril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction Circ. 96 1997 442 447